Inventor

HUANG HAICHUN

US81 patents

⚠️ This page may combine multiple inventors who share the name “HUANG HAICHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUANG HAICHUN

BRISTOL MYERS SQUIBB CO

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Binding molecules to the human OX40 receptor

Antibodies against CD73 and uses thereof

Antibodies against CD73

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)

Anti-GITR antibodies for cancer diagnostics

Antibodies against CD73

SQUIBB & SONS LLC

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Monoclonal antibodies to Programmed Death 1 (PD-1)

Methods for treating cancer using anti-PD-1 antibodies

Monoclonal antibodies to programmed death 1 (PD-1)

Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Monoclonal antibodies to programmed death 1 (PD-1)

Human monoclonal antibodies to O8E

AMGEN INC

Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors

Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

Human anti-B7RP1 neutralizing antibodies

Therapeutic human anti-IL1-R1 monoclonal antibody

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors

MEDAREX INC

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)

Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

MEDAREX LLC

Methods for treating cancer using anti-PD-1 antibodies

Therapeutic human anti-IL-1R1 monoclonal antibody

KORMAN ALAN J

Monoclonal antibodies to programmed death 1 (PD-1)

Human monoclonal antibodies to O8E

MIN JING

Binding molecules to the human OX40 receptor

Binding molecules to the human OX40 receptor

WILD JR KENNETH D

Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors

PFIZER

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Binding molecules to the human OX40 receptor

TERRET JONATHAN ALEXANDER

Human monoclonal antibodies to CD70

TEELING JESSICA

Human monoclonal antibodies against CD20

RAO-NAIK CHETANA

CD19 antibodies and their uses

DESHPANDE SHRIKANT

IP-10 antibodies and their uses

TERRETT JONATHAN ALEXANDER

Monoclonal antibodies against glypican-3

SIU GERALD

Human anti-B7RP1 neutralizing antibodies

NOVAROCK BIOTHERAPEUTICS LTD

Anti-CLauDiN 18 antibodies and methods of use thereof

WELCHER ANDREW A

Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors